300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 40 Biotechnology Angel Investors in Asia (October 2023)

The most active angel investors investing in Asia Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Asia Biotechnology startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Koki Yabu
Angel
2 Japan Angel, Pre-Seed Content, Finance, Data Mining $1.7M–$2.9M
Hua Guoping
Angel
1 China Series A Health Care, Biotechnology, Manufacturing
Ye Huahua
Angel
1 China Seed Medical, Health Care, Biotechnology
Johannes Hille
Angel
1 Singapore Seed Medical, Health Care, Biotechnology
Ron Sim
Angel
1 Singapore Series A Beauty, Fitness, Genetics
Suzhou Juming
Angel
1 China Series A Biotechnology
Bingqiang Gao
Angel
1 China, United States Seed, Angel Hardware, Coffee, Gaming
Hirofumi Miki
Angel
1 Japan Seed, Angel, Pre-Seed Content, Marketing, Internet $3.7M–$32M
Quek Siu Rui
Angel
1 Singapore, Indonesia Seed, Pre-Seed Health Care, Education, Information Technology $737k–$2.8M
Yutaka Matsuo
Angel
1 Japan Seed Artificial Intelligence, Neuroscience, Machine Learning
Paul Buchheit
Angel
1 United States, Canada, India Seed, Series A, Angel Software, Health Care, E-Commerce $100k–$8.5M
Jim Mellon
Angel
1 United States, United Kingdom, Israel Series A, Seed Biotechnology, Health Care, Food and Beverage $503k–$20M
Bas Godska
Angel
1 United States, The Netherlands, Kazakhstan Pre-Seed, Seed, Angel Software, E-Commerce, Machine Learning $200k–$2M
Jaynti Kanani
Angel
1 India, Singapore, United States Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Internet $1M–$11M
Nadav Rosenberg
Angel
1 United Kingdom, Israel, Singapore Seed, Pre-Seed, Series A Biotechnology, Artificial Intelligence, Pharmaceutical $2M–$2M
Kenshin Fujiwara
Angel
1 Japan Seed, Series A Mobile, Medical, Software
Sandeep Nailwal
Angel
1 United States, India, Singapore Seed, Pre-Seed, Series A Blockchain, Cryptocurrency, Financial Services $100k–$18M
Hidetoshi Takano
Angel
1 Japan, United States Seed, Angel Internet, Information Technology, Media and Entertainment $4.1M–$30M
Jason Zeng
Angel
1 China, United States Seed, Angel, Series B Artificial Intelligence, Machine Learning, Social Media
Kamata Tomihisa
Angel
1 Japan, United States Seed, Angel Fitness, Medical, Genetics
Jeffrey Tiong
Angel
1 Singapore Pre-Seed, Seed Health Care, Apps, Medical
Joel Neoh
Angel
1 Malaysia, Hong Kong Seed, Pre-Seed, Series A Apps, Mobile, Wellness
Yahui Zhou
Angel
1 China Series A Software, Health Care, Biotechnology
Bud Biswas
Angel
1 Singapore Seed Health Care, Biotechnology, Health Diagnostics
Matt Cutts
Angel
1 United States, Canada, Mexico Seed, Angel, Series A SaaS, Health Care, Software
Evan DiMeglio
Angel
1 United States, Canada, Singapore Seed, Pre-Seed, Series B E-Commerce, Apps, Mobile Payments
Benjamin Boyer
Angel
1 United States, China, Singapore Series C, Seed, Series B Software, Internet, E-Commerce $10M–$110M
Roy Oron
Angel
1 United States, Israel, Singapore Seed, Series B, Series A Software, Mobile, Biotechnology
Ravindran Govindan
Angel
1 Singapore Seed Health Care, Biotechnology, Health Diagnostics
Jack Wang
Angel
1 Singapore Seed Fertility, Biotechnology, Medical Device
Alice Foo
Angel
1 Singapore Pre-Seed Recycling, Biotechnology, Waste Management
Hiroaki Kitano
Angel
1 Japan, United States Seed, Angel, Debt Financing Health Care, Information Technology, Fitness $6.9M–$41M
Eric Urhane
Angel
1 United States, Mexico, Singapore Seed, Angel Software, Health Care, Biotechnology
Feng Hu
Angel
1 United States, India, Singapore Seed, Pre-Seed, Convertible Note Communities, Mobile Apps, Health Care
Yasunori Kaneko
Angel
1 Japan Seed Biotechnology
Talgat Ismail
Angel
1 Kazakhstan, Germany, United States Pre-Seed, Seed, Angel E-Learning, Apps, Biometrics $77k–$100k
Frederik Vandermarlie
Angel
1 Belgium, Singapore Seed Medical, Legal Tech, Health Care
Woyong Fund
Angel
1 China Seed Medical, Biotechnology, Pharmaceutical
Markus Haefeli
Angel
1 Hong Kong Seed Biotechnology
Jiang Guangce
Angel
1 China Seed Biopharma, Biotechnology, Pharmaceutical
Access all 40 angel investors in Asia Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Koki Yabu
Angel · Tokyo, Tokyo, Japan · 2 investments in Asia Biotechnology startups

Koki Yabu is Founder, President & CEO at Mobcast inc.

Show more...

Investment focus

  • Industry: Content, Finance, Data Mining
  • Stage:Angel, Pre-Seed
  • Geography: Japan

Investor stats

  • Total investments: 3
  • Round size: Angel $1.7M–$2.9M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Mobcast group — mobcast is a sports entertainment company that operates a mobile entertainment platform for smartphones and feature phones. It supports customers with social game and social media services. The company was founded in 2009 and is based in Tokyo, Japan. Currently, it operates as a subsidiary of mobcast Inc.
  • SmartApp Japan — Smart Apps is a developer of a blockchain services application designed for smartphones. The company's application uses cryptocurrency technology to offer token issuance, initial coin offering and dApps design support, providing a launchpad for start-up blockchain-related businesses.
Show all investments...

Hua Guoping
Angel · 1 investments in Asia Biotechnology startups

Hua Guoping is the the founder of Hualan Co.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Series A
  • Geography: China

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Boyi Biotechnology — Boyi Biotechnology is a technology-based firm that provides vital raw materials and complete solutions to biomedical customers in the in vitro diagnostic market. It focus on diagnostic microspheres, testing raw materials, and quality control products.
Show all investments...

Ye Huahua
Angel · 1 investments in Asia Biotechnology startups

Ye Huahua is an Angel investor.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: China

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Ruier Weikang — Ruier Weikang focuses on the development and commercialization of brain scientific disease diagnostic, monitoring, and therapy products.
Show all investments...

Johannes Hille
Angel · 1 investments in Asia Biotechnology startups

Johannes Hille

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
Show all investments...

Ron Sim
Angel · 1 investments in Asia Biotechnology startups

Ron Sim

Show more...

Investment focus

  • Industry: Beauty, Fitness, Genetics
  • Stage:Series A
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Imagene Labs — Imagene Labs Pte Ltd empowers consumers to optimise their health by providing customised wellness and lifestyle solutions tailored to their unique DNA profiles. Led by medical doctors and scientists, the company provides an entire ecosystem of genomics-based solutions ranging from wellness DNA tests, personalised lifestyle recommendations, bespokeskin serums and nutritional supplements, and mobile health apps that help people live, look and feel their best.
Show all investments...

Suzhou Juming
Angel · 1 investments in Asia Biotechnology startups

Suzhou Juming

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Series A
  • Geography: China

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Zion Pharma — Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.
Show all investments...

Bingqiang Gao
Angel · 1 investments in Asia Biotechnology startups

Bingqiang Gao is the Independent Non-Executive Director of Q Tech.

Show more...

Investment focus

  • Industry: Hardware, Coffee, Gaming
  • Stage:Seed, Angel
  • Geography: China, United States

Investor stats

  • Total investments: 6
  • Lead/follow: no public data

Portfolio highlights

  • Z·Pilot — ZPilot is a stylish electronic new retail brand that combines contemporary toys and digital art to present viewers with a deeper visual.
  • Insep Technology — Insep Technology is an insect protein technology and product developer.
  • Changyao Innovation — Changyao Innovation is a cutting-edge technological company. It provides intelligent robots to families. The current first-generation devices emphasize automating the entire grass management process. The main focus is on robotic lawnmowers with a vision-based full process.
Show all investments...

Hirofumi Miki
Angel · Shibuya, Kanagawa, Japan · 1 investments in Asia Biotechnology startups

After JTB Co., Ltd. and CYBIRD Co., Ltd. as an initial member of Glee Co., Ltd. is responsible for business development. Currently, he is mainly engaged in venture support in the Internet area, investing in venture and venture capital, and served as management advisor for dozens of companies. Hands-on business development, growth strategydevelopment, financing advice, HR organization design support, partner referral and Recruit Support. He is also engaged in business support for ventures in the healthcare and university venture fields. He served as Digital Health Meetup Advisor, NEDOTCP Mentor and Future 2016 Mentor.

Show more...

Investment focus

  • Industry: Content, Marketing, Internet
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Japan

Investor stats

  • Total investments: 25
  • Round size: Seed $3.7M–$32M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • AceRNA — AceRNA contributes to regenerative medicine and drug discovery through the discovery of novel miRNA functions. It began operation in April 2018, with its headquarters in Kyoto in Japan.
  • Epicbase — Epicbase is an AI-based automatic voice transcription service based on voice recognition technology.
  • Go Visions — Go Visions engages in the edutainment tech for children and human resources services.
Show all investments...

Quek Siu Rui
Angel · Singapore, Central Region, Singapore · 1 investments in Asia Biotechnology startups

Siu Rui is a co-founder of Carousell and oversees Product and Marketing. Since the launch of Carousell in May 2012 together with co-founders Marcus Tan and Lucas Ngoo, Siu Rui has been deeply involved in product strategy, international expansion and capital strategy. He is passionate about technology and has been buying and selling online since hewas 13. This has been a driving force behind Siu Rui’s commitment to building a product-focused company, focused on solving meaningful problems for people globally.Prior to Carousell, Siu Rui spent some time in marketing and product management at VSee, Ogilvy & Mather and DBS Vickers. Siu Rui read Business Administration and Entrepreneurship at National University of Singapore and Stanford University (Under the NUS Overseas College Program in Silicon Valley, California), and dropped out of his Honours year to start Carousell.

Show more...

Investment focus

  • Industry: Health Care, Education, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Singapore, Indonesia

Investor stats

  • Total investments: 10
  • Round size: Seed $737k–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Jackett — Jackett is your assessment automation platform for eliminating the hassle of writing & marking (quizzes, tests, worksheets, homework) - and so much more.
  • NodeFlair — NodeFlair aims to help tech talents make better career decisions through jobs, salaries, reviews, company insights, and more
  • Mito Health — An AI-Powered medical team dedicated to optimising your health. Focusing on in-depth diagnostics and evidence-based strategies across 5 key pillars of nutrition, sleep, exercise, supplements and mental well-being.
Show all investments...

Yutaka Matsuo
Angel · Tokyo, Tokyo, Japan · 1 investments in Asia Biotechnology startups

1997 Graduated from Tokyo University, Department of Electronic and Information Engineering. In 2002, he completed the doctoral program at the same graduate school. Ph.D. (Engineering) He was a researcher at the Institute of Industrial Science and Technology since the same year. After working as a visiting researcher at Stanford University in August2005, Associate Professor of Technology Management Strategy, Institute of Research, Graduate School of Engineering, University of Tokyo in 2007. Co-Representative, Associate Professor, Global Consumption Intelligence Donation Course, Department of Technology Management Strategy, Graduate School of Engineering, Tokyo University. Professor from 2019, Graduate School of Engineering, Tokyo University of Engineering, Department of Technology Management Strategy. He specializes in artificial intelligence, web mining, big data analytics. The Society of Artificial Intelligence received the Paper Award (2002), the 20th Anniversary Project Award (2006), the Field Innovation Award (2011), and the Merit Award (2013). At the Society of Artificial Intelligence, he has been a student editorial committee and an editorial committee, and vice chair/director since 2010. Chairman of Ethics from 2014 to 2018. Chairman of Japan Deep Learning Association since 2017.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Neuroscience, Machine Learning
  • Stage:Seed
  • Geography: Japan

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • DeepX — DeepX is an AI startup company based in Tokyo that was founded in 2016 by graduates from the University of Tokyo, Japan’s leading institution of higher education. After three strong years of establishing ourselves, we continue to grow and are ready to make an impact on society through our work. Our core mission is to ‘automate any machinery’ andsupported by our successful projects, we believe that Deep Learning and its real-world implementations will bring an unprecedented breakthrough to solve current and future societal problems. A key challenge that Japan is currently facing is a super-aging society and a shrinking labor population leading to shortages. We develop software to automate machines ranging from small industrial robots to big heavy equipment. Our control models can achieve flexible operation for various environments and conditions using cutting-edge technology such as Deep Reinforcement Learning.
  • MinD in a Device — MinD in a Device Co., Ltd. is a university-launched venture that aims to port human consciousness to devices (machines and computers) in the medium to long term based on long-term research results on consciousness. As the first step toward realization, we will evolve and deepen the "generation model" considered to be the source ofconsciousness, and promote the development of next-generation AI and social implementation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Paul Buchheit
Angel · Mountain View, California, United States · 1 investments in Asia Biotechnology startups

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 102
  • Round size: Seed $1M–$5M; Angel $100k–$1M; Series A $650k–$8.5M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
  • Character.ai — character.ai is bringing to life the science-fiction dream of open-ended conversations and collaborations with computers.
  • Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Jim Mellon
Angel · 1 investments in Asia Biotechnology startups

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Food and Beverage
  • Stage:Series A, Seed
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 26
  • Round size: Seed $503k–$20M; Series A $2.8M–$4.3M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Amy — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
  • Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
  • The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.
Show all investments...

Bas Godska
Angel · Amsterdam, Noord-Holland, The Netherlands · 1 investments in Asia Biotechnology startups

General Partner & Founder Acrobator Ventures, Tech Investment Fund. Founder Acrobator.com, growth hack and marketing advisory firm. Digital Dutchman, entrepreneur-turned-investor. eCommerce expert, growth hacker and marketeer since 2000. Assisted 100+ companies worldwide as CMO, MD, board advisor, consultant. Personal angel investmentportfolio, overall company value nearing $3BN, follow-ons raised (>$150 MN) from Accel, Iconiq, Insight Ventures, EBRD, Techstars, Acrobator Ventures. Ranked #1 Foreign Angel Investor in Russia (EWDN); Top 10 Angel Investor (Firrma.ru/SLON), Crunchbase: #1 Dutch (2019) & Top 50 EU angel investor. Techcrunch / Crunchbase: "Bas Godska is one of the most prolific Western investors in Eastern Europe."Roles Europe/Russia/CIS (2003-2019): CMO lastminute.com ; Country Manager Sportingbet ; CMO Europe Ebookers.com / Orbitz.com ; MD Gogol Media. CMO / dep. CEO Ozon.ru ; VP Marketing Gloria Jeans ; CMO Lamoda.ru (Rocket Internet) ; CMO Digital KupiVIP.ru ; eCommerce Director a.i. Enter | Svyaznoi ; MD myThings.com ; Guest Lecturer Digital Marketing at Moscow School of Management MBA (3 years).Portfolio: miro.com; harver.com; travelata.ru (co-founder); Chocofamily Holding: chocotravel.kz, chocolife.me, aviata.kz, chocomart.kz (exit), lensmark.kz, rahmet.kz, chocofood.kz, iDoctor.kz, HRbot; Newzmate.com (partial exit to Piano.io); storyterrace.com, getobjectiv.com; Crossss (sold to Leadhit); clockster.com; linkpizza.com; zakaz.ua; urbandine.nl; 6nomads.com, instreamatic.ai., omdena.com, aura-aware.com, awesomic.com, memoryOS.com, VC investments: leapfunder.com; respeecher.com; letsenhance.io; studyfree.org.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Machine Learning
  • Stage:Pre-Seed, Seed, Angel
  • Geography: United States, The Netherlands, Kazakhstan

Investor stats

  • Total investments: 40
  • Round size: Seed $200k–$2M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Awesomic — Get matched with the best-fit designer on a fixed budget with no stress. Place a design task and see the first results on the next business day. Start today!
  • SuperWorld — The Virtual World mapped on top of the real world to create, discover and monetize content.
  • knopka — knopka - is an advanced automated nurse calling system that ensures help is provided on time. One-hour installation. Completely wireless. Compatible with cardiac monitors, fitness trackers, and smartwatches.
Show all investments...

Jaynti Kanani
Angel · Bengaluru, Karnataka, India · 1 investments in Asia Biotechnology startups

Jaynti Kanani - Co-Founder @ Polygon

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Internet
  • Stage:Seed, Pre-Seed, Series A
  • Geography: India, Singapore, United States

Investor stats

  • Total investments: 32
  • Round size: Seed $1.5M–$11M; Pre-Seed $1M–$1.8M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Nxyz — The most powerful blockchain data APIs for web3 developers. Fast and reliable, web3 indexing for querying networks like Ethereum, BSC, Polygon to get transactions, NFTs and more.
  • Rep3 — Rep3 is a Web3 community management application. Rep3 uses gamification methods to assist lps encryption projects in managing communities, members, and contributions.
  • AnotherBall — AnotherBall = Digital + Entertainment + Token economy
Show all investments...

Nadav Rosenberg
Angel · London, England, United Kingdom · 1 investments in Asia Biotechnology startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Pharmaceutical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, Israel, Singapore

Investor stats

  • Total investments: 13
  • Round size: Pre-Seed $2M–$2M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • thymia — Making mental health as objectively measurable as physical health.
  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Loops — Loops is a no-code analytics platform that provides product and data teams with growth opportunities hidden in their data.
Show all investments...

Kenshin Fujiwara
Angel · Kyoto, Kyoto, Japan · 1 investments in Asia Biotechnology startups

Kenshin is a CEO at Hacarus Inc., a healthcare technology startup based in Kyoto, Japan.He co-founded several tech startups with 2 exits in the past 15 years. His first career started as an engineer at Sony Computer Entertainment and worked on PlayStation development projects. HIs fist startup was acquired by Japanese public company, and thesecond startup was sold to the US company.Born in 1976. He holds a Computer Science degree from California State University. He loves mountain hiking and currently living in Kyoto Japan with his wife and family.

Show more...

Investment focus

  • Industry: Mobile, Medical, Software
  • Stage:Seed, Series A
  • Geography: Japan

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Helpfeel — Our vision is to make saving, sharing, and exploring ideas as natural as breathing. On this journey we're humbled to be helping millions around the world from solo makers to university research labs, from gamers to pro designers, and large to small teams like ours.
  • HACARUS — We make AI work, where common Big Data aproaches fail. Get explainable results, even from small data amounts. Available on the cloud or as embedded devices.
Show all investments...

Sandeep Nailwal
Angel · Mumbai, Maharashtra, India · 1 investments in Asia Biotechnology startups, 24 in the past 12 months

Sandeep Nailwal is the Co-Founder of Polygon. He is a former Co-Founder and CEO of Scopeweaver. He attended the National Institute of Industrial Engineering.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Financial Services
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 107
  • Round size: Seed $900k–$5.1M; Pre-Seed $100k–$1.3M; Series A $4.1M–$18M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Rep3 — Rep3 is a Web3 community management application. Rep3 uses gamification methods to assist lps encryption projects in managing communities, members, and contributions.
  • Orb — A community-focused social app for people to connect, interact, and transact in their daily lives on web3 built with Lens Protocol.
  • Lens Protocol — Lens Protocol is a composable and decentralized social graph, ready for you to build on so you can focus on creating a great experience, not scaling your users.
Show all investments...

Hidetoshi Takano
Angel · Tokyo, Tokyo, Japan · 1 investments in Asia Biotechnology startups

Joined Intelligence in 1999. Established Key Players Inc. in 2005. Consultation with more than 3,000 managers and career counseling for more than 10,000 individuals. In addition, we have invested in more than 55 outside directors, advisors and angels in Silicon Valley and Bangladesh in Japan. Over 100 lectures on careers, entrepreneurship andstartups.

Show more...

Investment focus

  • Industry: Internet, Information Technology, Media and Entertainment
  • Stage:Seed, Angel
  • Geography: Japan, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $5.5M–$9.1M; Angel $4.1M–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Cocoach — Cocoach provides online education service.
  • Data Viz Lab — Data Viz Lab is a platform that offers data analysis, visualization consulting, and data human resource development support.
  • ElevationSpace — ElevationSpace offers high quality & well equipped workspaces giving tenants a nurturing environment .
Show all investments...

Jason Zeng
Angel · Shenzhen, Guangdong, China · 1 investments in Asia Biotechnology startups

Jason Zeng, one of the Core Founders and Advisor Emeritus of Tencent Group. Jason founded the Group in 1999. As the Chief Operating Officer during 1999 and 2007, Jason was responsible for overseeing the Company's business lines and product portfolios and the managing the Company’s sales and marketing activities across China. Prior toTencent, Jason worked in the Shenzhen Data Telecommunications Bureau and was familiar with the Internet and telecommunications industries in China. Since June 2007, Jason has been the Advisor Emeritus of the Company.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Machine Learning, Social Media
  • Stage:Seed, Angel, Series B
  • Geography: China, United States

Investor stats

  • Total investments: 9
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Quivr — A new way to date. Let matchmakers do the work for you or play Cupid yourself.
  • Quivr — Quivr empowers you to take control of your digital identity, making it easier to connect with a community that truly shares your passions and values.
  • Little Spoonful — Little Spoonful 小勺满满 provides fresh, safe, and nutritious foods for children in China.
Show all investments...

Kamata Tomihisa
Angel · Tokyo, Tokyo, Japan · 1 investments in Asia Biotechnology startups

Dr. Kamada earned his Ph.D. at the University of Tokyo. In 1984, he pursued his journey to establish his own business that focused on information appliances and mobile software, namely ACCESS Co., Ltd.. With great success, the company entered the Tokyo Stock Exchange Mothers Market in 2001. He left ACCESS Co., Ltd. in 2011, and founded TomyK Ltd.in 2012 where he supports startups possessing revolutionary business ideas that revitalize the Japanese economy.

Show more...

Investment focus

  • Industry: Fitness, Medical, Genetics
  • Stage:Seed, Angel
  • Geography: Japan, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Activaid — Activaid owns and operates a social data platform for patients with inflammatory bowel disease. It allows patients to support and exchange information within the patient community with the same disease; provide information necessary for new drug development and matching to clinical trials that suits them; and improve medical treatment. YasuakiHasebe founded Activaid in 2018. It has its headquarters in Tokyo in Japan.
  • Genomelink — Genomelink is a platform where people discover more with their DNA data and help businesses build, market and do research with it. The best founders in consumer genomics with real experience in the industry for many years, including M3, Inc. ($13B valued Meditech in Japan), a founding member of the Japanese version of 23andMe, and leadbioinformatician and software engineer at a joint-venture between Illumina and Sony. Raised $4M for Seed Round from Berkeley SkyDeck, SONY, and top-tier Japanese VCs. Supported by Illumina Accelerator, Carlos Bustamante Lab at Stanford University among others.
  • MinD in a Device — MinD in a Device Co., Ltd. is a university-launched venture that aims to port human consciousness to devices (machines and computers) in the medium to long term based on long-term research results on consciousness. As the first step toward realization, we will evolve and deepen the "generation model" considered to be the source ofconsciousness, and promote the development of next-generation AI and social implementation.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Jeffrey Tiong
Angel · 1 investments in Asia Biotechnology startups

Jeffrey is passionate about leveraging technology to help companies innovate more successfully. Since founding PatSnap fresh out of college, Jeffrey’s unique ability to merge technology, product design, strategy and marketing has helped it become the fastest-growing company in the industry, with operations across Singapore, China and London.Jeffrey sets the vision for the company and its products, and drives relentless execution across all fronts. Jeffrey earned a Bachelor’s degree in Biomedical Engineering from the National University of Singapore.

Show more...

Investment focus

  • Industry: Health Care, Apps, Medical
  • Stage:Pre-Seed, Seed
  • Geography: Singapore

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MindFi — MindFi is an employee mental health and well-being app delivering personalized self-care recommendations, support, and behavioral coaches. MindFi enables people to achieve peak mental performance.
  • Mito Health — An AI-Powered medical team dedicated to optimising your health. Focusing on in-depth diagnostics and evidence-based strategies across 5 key pillars of nutrition, sleep, exercise, supplements and mental well-being.
  • StratifiCare — At StratifiCare, we focus on the development and manufacturing of IVD (In-Vitro Diagnostics) assay solutions for personalized medicine. With more than 50 years of cumulative in-depth experience in Biomedical R&D and technology commercialization, StratifiCare strives to empower personalised medicine.
Show all investments...

Joel Neoh
Angel · Kuala Lumpur, Kuala Lumpur, Malaysia · 1 investments in Asia Biotechnology startups

Joel Neoh is the Founder and CEO of Fave. He attended Monash University.

Show more...

Investment focus

  • Industry: Apps, Mobile, Wellness
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Malaysia, Hong Kong

Investor stats

  • Total investments: 5
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • KFit — KFit gets you into the best fitness studios, classes and gyms in your city. Get access to unlimited group fitness classes and activities with just one monthly membership. Transform your workouts.Never get bored. Discover new ways to move. Take as many classes per month as you’d like. Try a different studio everyday. It’s time to work out the wayyou want to.
  • Ejen2u — Platform Sistem Pengurusan Ejen paling Komprehensif
  • ULive — Live Commerce Enabler for Social Media Live Sellers.
Show all investments...

Yahui Zhou
Angel · 1 investments in Asia Biotechnology startups

Zhou Yahui is the founder and Chairman of Kunlun. He previously worked at Thousand Oaks Group as a senior director and vice president. Zhou Yahui attended Tsinghua University.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A
  • Geography: China

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • NeoCura — NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.
Show all investments...

Bud Biswas
Angel · San Jose, California, United States · 1 investments in Asia Biotechnology startups

Bud has an impressive track record of starting networking companies and turning them into profitable businesses, and has over twenty years of industry experience in the field of high speed networking, in both technical and managerial positions. He founded Digital Technology, which was acquired by Agilent Technologies in the year 2000. He was alsoone of the founding partners of Network Software, a networking consulting company, and CCS, one of the first portable PC companies of the early 80's. Bud has an MS in Electrical Engineering and an MS in Computer Science from Ann Arbor, Michigan.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cardiotrack — uber Diagnostics is engaged in mHealth space to deliver diagnostics solutions that significantly improve patient care in developing nations. Key challenges faced by healthcare providers include very high cost of diagnostics equipment and lack of trained professionals in semi-urban and rural areas. uber Diagnostics is addressing both of theseissues through innovation in medical electronics and research in cloud based IT infrastructure.
Show all investments...

Matt Cutts
Angel · San Francisco, California, United States · 1 investments in Asia Biotechnology startups

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Show more...

Investment focus

  • Industry: SaaS, Health Care, Software
  • Stage:Seed, Angel, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 11
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Meter Feeder — Easily pay for parking through MeterFeeder
Show all investments...

Evan DiMeglio
Angel · 1 investments in Asia Biotechnology startups

Evan DiMeglio

Show more...

Investment focus

  • Industry: E-Commerce, Apps, Mobile Payments
  • Stage:Seed, Pre-Seed, Series B
  • Geography: United States, Canada, Singapore

Investor stats

  • Total investments: 5
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cyble — Cyble is a leading threat intelligence provider that obtains and processes data from the dark web and OSINT to mitigate external cybersecurity risks
  • TurtleTree — TurtleTree is unlocking a new generation of dairy-based functional nutrition using modern precision fermentation technology.
  • Triumph — Triumph is a gaming monetization platform provider. They provide iPhone games on one line of code drop-in SDK. They handle the entire tournament stack by player matching, payment, arbitration, and compliance. They transform the game into money tournaments.
Show all investments...

Benjamin Boyer
Angel · San Francisco, California, United States · 1 investments in Asia Biotechnology startups

Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000.Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments.Ben holds an M.B.A. from Stanford Graduate Schoolof Business and a B.S. in human and organizational development from Vanderbilt University.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Series C, Seed, Series B
  • Geography: United States, China, Singapore

Investor stats

  • Total investments: 21
  • Round size: Series B $12M–$50M; Series C $10M–$110M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Kangaroo — No hidden upfront costs or astronomical monthly monitoring fees. Our plans are contract-free, flexible and affordable. We even help you earn cash back on your insurance policy! Our sensors are batteries-included, peel-and-stick, app-controlled easy. Choose a free plan or professionally monitored plan for only $99/yr.
  • People.ai — Uncover the Fastest Path to Revenue
  • Triparound — Get access to the ultimate travel planning platform for maximized ancillary revenue and operational efficiency!
Show all investments...

Roy Oron
Angel · 1 investments in Asia Biotechnology startups

Roy Oron is the founder and general partner at ITI Venture Capital Partners.

Show more...

Investment focus

  • Industry: Software, Mobile, Biotechnology
  • Stage:Seed, Series B, Series A
  • Geography: United States, Israel, Singapore

Investor stats

  • Total investments: 12
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Vayyar — With applications in the automotive, smart home, robotics, retail, RF testing and medical sectors, Vayyar's intelligent sensors can see through walls and objects, tracking movement in real time in all environmental conditions. Its state-of-the-art Radar-on-Chip covers imaging and radar bands from 3-81 GHz, with up to 72 transceivers on eachchip and an integrated high-performance DSP delivering unprecedented levels of accuracy and generating high-resolution 4D point cloud images. Vayyar is developing the next generation of sensing technology that is miniature, affordable and versatile enough to impact everyone's lives. Welcome to a world where intelligent sensing is part of the everyday.
  • Enzootic — Enzootic is a vertically integrated genetic freshwater shrimp company
  • proteanTecs — proteanTecs' platform applies machine learning & analytics to data from chip-embedded Agents providing insights & predictions on performance and reliability.
Show all investments...

Ravindran Govindan
Angel · Singapore, Central Region, Singapore · 1 investments in Asia Biotechnology startups

Ravindran Govindan - Executive Chairman and founder @ Eight Mercatus

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cardiotrack — uber Diagnostics is engaged in mHealth space to deliver diagnostics solutions that significantly improve patient care in developing nations. Key challenges faced by healthcare providers include very high cost of diagnostics equipment and lack of trained professionals in semi-urban and rural areas. uber Diagnostics is addressing both of theseissues through innovation in medical electronics and research in cloud based IT infrastructure.
Show all investments...

Jack Wang
Angel · 1 investments in Asia Biotechnology startups

Jack Wang

Show more...

Investment focus

  • Industry: Fertility, Biotechnology, Medical Device
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Alice Foo
Angel · 1 investments in Asia Biotechnology startups

Alice Foo is an angel investor for Alterpacks.

Show more...

Investment focus

  • Industry: Recycling, Biotechnology, Waste Management
  • Stage:Pre-Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • AlterPacks — Alterpacks - Food Waste Solutions. A Singapore Management University, Institute of Innovation & Entrepreneurship, Business Innovation Generator (BIG) Incubatee.
Show all investments...

Hiroaki Kitano
Angel · 1 investments in Asia Biotechnology startups

Hiroaki Kitano is the SVP at Softbank Mobile. He attended Waseda University.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Fitness
  • Stage:Seed, Angel, Debt Financing
  • Geography: Japan, United States

Investor stats

  • Total investments: 6
  • Round size: Seed $6.9M–$41M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GPx — GPx is a biotech company that revolutionizes remote chronic disease management with bloodless blood tests. It is dedicated to transforming the standard of care of cardiorenal diseases and enabling patients to better understand their condition, much like the continuous glucose monitor has transformed diabetes care.The company was founded in 2020and is based in Boston, Massachusetts.
  • Epistra — Epistra accelerates research and development in life sciences.
  • Activaid — Activaid owns and operates a social data platform for patients with inflammatory bowel disease. It allows patients to support and exchange information within the patient community with the same disease; provide information necessary for new drug development and matching to clinical trials that suits them; and improve medical treatment. YasuakiHasebe founded Activaid in 2018. It has its headquarters in Tokyo in Japan.
Show all investments...

Eric Urhane
Angel · 1 investments in Asia Biotechnology startups

Eric Urhane

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Angel
  • Geography: United States, Mexico, Singapore

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Show all investments...

Feng Hu
Angel · 1 investments in Asia Biotechnology startups

Feng Hu

Show more...

Investment focus

  • Industry: Communities, Mobile Apps, Health Care
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
  • DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
  • Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.
Show all investments...

Yasunori Kaneko
Angel · 1 investments in Asia Biotechnology startups

Yasunori has been involved in managing and financing US life sciences companies since 1981. He began his career at Genentech (NYSE: DNA), where he spearheaded its business development activities for the first several years. He was then Project Manager for the launch of Protropin (human growth hormone), the first product marketed by Genentech. In1987, he became head of corporate finance in the investment banking division of Paribas Capital Markets LTD in Tokyo, where he helped finance Japanese government agencies, municipalities and corporations in the Euro market. He also helped numerous life sciences companies raise capital. He then became Senior Vice President and CFO of Isis Pharmaceuticals (NASDAQ: ISIS), which went public during his tenure there. In 1992, he was recruited to be the original business executive at Tularik (acquired by Amgen in 2004), where at various times he was CFO and VP-Business Development until its public offering in 1999. He served on the board of LeukoSite until its merger with Millennium Pharmaceuticals (NASDAQ: MLNM) in 1999. He received an undergraduate degree from Keio University in Tokyo, a medical degree from Keio University School of Medicine, and an M.B.A. from Stanford Business School. He joined Skyline in 1999. He committed to golf several years ago after an unfortunate heading incident at a team reunion for his junior All-Star soccer team.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed
  • Geography: Japan

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Logomix Inc. — Logomix Inc is a mammalian cellular genome architect startup. Logomix proprietary platform, Geno-Writing™, technology integrates large-scale (Mb) human genome-writing technologies and providing genetically architected versatile human cells and/or downsized cells and microbes for drug development and cell & gene therapy area.Majority ofthe cell engineering companies are currently focused on optimization of gene clusters by automatic high throughput system however, Logomix’s Geno-Writing™ provides the required tools for dealing with mammalian or complex genomes. Logomix works with partners by providing new biology-based solutions to co-create business and social values on Geno-Writing™ platform Current Focus Area includes: 1. Human Health & Therapeutics 2. Biomaterials & Chemicals 3. Agriculture & EnvironmentLogomix has 11 ongoing collaborative research partnerships. Currently Logomix is specifically looking for industry partners to address unmet needs in neurodegenerative disease areas.
Show all investments...

Talgat Ismail
Angel · Almaty, Almaty City, Kazakhstan · 1 investments in Asia Biotechnology startups

Talgat Ismail

Show more...

Investment focus

  • Industry: E-Learning, Apps, Biometrics
  • Stage:Pre-Seed, Seed, Angel
  • Geography: Kazakhstan, Germany, United States

Investor stats

  • Total investments: 6
  • Round size: Pre-Seed $77k–$100k
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • Steppix — Access well structured online dance lessons that pull you in. Discover Steppix: professional dance floors and streaming dance classes to you live and on-demand.
  • Clockster — We help small and medium businesses cut HR overhead by automating payroll, attendance and more at no cost
  • Kid Security — Kid Security is a mobile application for child safety.
Show all investments...

Frederik Vandermarlie
Angel · 1 investments in Asia Biotechnology startups

Frederik Vandermarlie

Show more...

Investment focus

  • Industry: Medical, Legal Tech, Health Care
  • Stage:Seed
  • Geography: Belgium, Singapore

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
  • Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.
Show all investments...

Woyong Fund
Angel · 1 investments in Asia Biotechnology startups

Woyong Fund is an individual investor.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Pharmaceutical
  • Stage:Seed
  • Geography: China

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Boyin Bio — Boyin Bio is an innovative biomaterial research and development and application enterprise.
Show all investments...

Markus Haefeli
Angel · 1 investments in Asia Biotechnology startups

Markus Haefeli is Chairman of PTG Food and Regal Springs.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Seed
  • Geography: Hong Kong

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Avant Meats — They focus on technology, commercial product innovation, and branding as well as intellectual property portfolio building in the area of ‘cell-based’ animal protein food products.
Show all investments...

Jiang Guangce
Angel · 1 investments in Asia Biotechnology startups

Dr. Jiang Guangce is the chairman of Dechuan Medical Fund.

Show more...

Investment focus

  • Industry: Biopharma, Biotechnology, Pharmaceutical
  • Stage:Seed
  • Geography: China

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Renjing Biology — Renjing Biotech is committed to the research and development of innovative drugs based on messenger ribonucleic acid (mRNA).
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology Angel Investors in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 angel investors investing in Asia Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists